NCT02660112 - (+) Epicatechin to Treat Friedreich's Ataxia | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

December 30, 2018

Study Completion Date

December 30, 2018

Conditions

Friedreich's Ataxia

Interventions

DRUG

(+)-Epicatechin

25mg (+)-Epicatechin capsules. Starting dose 75mg total daily dose (one 25mg cap taken three times per day). Dose escalation at 12 weeks for non-responders to 150mg total daily dose (two 25mg caps taken three times per day)

Trial Locations (1)

55905

Mayo Clinic, Rochester